Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

SmartFinancial Reports 2024 Q4 Net Income Surge

SmartFinancial, Inc. has reported a significant increase in net income for the fourth quarter of 2024. The company's net income stood at $9.6 million, or $0.57 per diluted common share, compared to $6.2 million, or $0.37 per diluted common share, for the same period in 2023. Moreover, operating earnings, which exclude non-recurring income, net of tax adjustments, totaled $9.6 million, or $0.57 per diluted common share, in the fourth quarter of 2024, compared to $6.9 million, or $0.41 per diluted common share, in the fourth quarter of 2023.

SmartFinancial also saw a notable increase in net organic loan and lease growth, with a 20% annualized quarter-over-quarter increase equating to $189 million. The net interest income for the fourth quarter of 2024 was reported at $37.8 million, compared to $35.0 million for the previous quarter, with average earning assets totaling $4.7 billion, representing an increase of $151.0 million from the prior quarter.

One of the key highlights was the quarter-over-quarter net tax equivalent interest margin expansion of 13 basis points to 3.24%. This expansion was primarily driven by the decreased cost of interest-bearing deposits. The yield on loans and leases, excluding loan fees, remained constant at 5.95% quarter-over-quarter. Additionally, the cost of total deposits for the fourth quarter of 2024 was 2.43%, down from 2.54% in the prior quarter.

SmartFinancial's credit quality remained solid, with nonperforming assets to total assets standing at 0.19%. The company's chairman, Miller Welborn, expressed satisfaction with the company’s 10% annual tangible book value growth and steady return metric enhancement.

As a result of these announcements, the company's shares have moved 1.9% on the market, and are now trading at a price of $32.18. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS